article Open AccessTop 1% cited
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology · 2014 · Vol. 15(12) · pp. e538–e548
S. Vincent Rajkumar✉Meletios Α. Dimopoulos(National and Kapodistrian University of Athens)Antonio Palumbo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)Joan Bladé(Hospital Clínic de Barcelona)Giampaolo Merlini(Policlinico San Matteo Fondazione)María‐Victoria Mateos(Instituto de Investigación Biomédica de Salamanca)Shaji Kumar(Mayo Clinic in Arizona)Jens Hillengaß(Heidelberg University)Efstathios Kastritis(National and Kapodistrian University of Athens)Paul G. Richardson(Dana-Farber Cancer Institute)Ola Landgren(Memorial Sloan Kettering Cancer Center)Bruno Paiva(Clinica Universidad de Navarra)Angela Dispenzieri(Mayo Clinic in Arizona)Brendan M. Weiss(University of Pennsylvania)Xavier LeleuSonja Zweegman(Amsterdam UMC Location VUmc)Sagar Lonial(Emory University)Laura Rosiñol(Hospital Clínic de Barcelona)Elena ZamagniSundar Jagannath(Tisch Cancer Institute)Orhan Sezer(Istanbul Memorial Hospital)Sigurður Y. Kristinsson(Karolinska Institutet)Jo Caers(Centre Hospitalier Universitaire de Liège)Saad Z. Usmani(Levine Cancer Institute)Juan José Lahuerta(Hospital Universitario 12 De Octubre)Hans Erik Johnsen(Aalborg University Hospital)Meral Beksaç(Ankara University)Michèle CavoHartmut Goldschmidt(Heidelberg University)Evangelos Terpos(National and Kapodistrian University of Athens)Robert A. Kyle(Mayo Clinic in Arizona)Kenneth C. Anderson(Dana-Farber Cancer Institute)Brian G.M. Durie(Cedars-Sinai Medical Center)Jesús F. San Miguel(Clinica Universidad de Navarra)
Multiple Myeloma Research and TreatmentsPeptidase Inhibition and AnalysisProtein Degradation and InhibitorsMultiple myelomaMedicineDiseaseIntensive care medicineIdentification (biology)Bone diseaseHypercalcaemiaOncologyInternal medicineOsteoporosis
MeSH terms
Bone Marrow CellsHumansMultiple MyelomaPrognosisBiomarkers, TumorRenal Insufficiency
Citations
4,761
FWCI
138.40
field-weighted impact
References
107
Percentile
100%
vs. same field & year
Citations per year
Cited by
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
Transplantation · 2020 · 636 citations
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Blood · 2015 · 1,891 citations
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2017 · 866 citations
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology · 2016 · 2,897 citations
Multiple Myeloma: Diagnosis and Treatment
Mayo Clinic Proceedings · 2016 · 806 citations
Plasma cell dyscrasias with complete loss of immunoglobulin heavy chain expression: A rare case
International Journal of Advanced Biochemistry Research · 2022 · 0 citations
References
Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Clinical Chemistry · 2001 · 639 citations
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
Leukemia · 2008 · 1,109 citations
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
Leukemia · 2008 · 802 citations
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Mayo Clinic Proceedings · 2003 · 2,410 citations
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Leukemia · 2009 · 481 citations
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
British Journal of Haematology · 2003 · 2,306 citations
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Leukemia · 2010 · 860 citations
Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
Clinical Chemistry · 2002 · 609 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.